WHO ICTRP trial

A comparative study of HyperHAES (7.2% NACL and 6% hydroxyethyl starch) and 20%…

EUCTR2005-005319-66-GB · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2005-005319-66-GB
Public title A comparative study of HyperHAES (7.2% NACL and 6% hydroxyethyl starch) and 20% mannitol in the treatment of elevated intracranial pressure after brain injry - A comparison of HyperHAES and mannitol on raised intracranial pressure
Scientific title A comparative study of HyperHAES (7.2% NACL and 6% hydroxyethyl starch) and 20% mannitol in the treatment of elevated intracranial pressure after brain injry - A comparison of HyperHAES and mannitol on raised intracranial pressure
Primary sponsor Research and Development Office, Royal Infirmary of Edinburgh
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries United Kingdom
Conditions elevated intracranial pressure after brain injury
Interventions Trade Name: HypeHAES Product Name: freeflex Product Code: hyperhaes Pharmaceutical Form: Intravenous infusion Pharmaceutical form of the placebo: Intravenous infusion Route of administration of the placebo: Intravenous use
Registration date Oct 4, 2006
Target size 16
Secondary IDs 2005/W/AN/02
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations